Analysis

Earnings Preview: What to watch as Intel (INTC) prepares to report Q4 results

For Intel Corporation (NASDAQ: INTC), 2025 marked a recovery year, as the company made notable progress towards achieving its technological and operational

Key takeaways from Delta Air Lines’ (DAL) Q4 2025 earnings report

Shares of Delta Air Lines (NYSE: DAL) were down over 2% on Tuesday after the company published its fourth quarter 2025 earnings

Johnson & Johnson heads into Q4 as a more focused healthcare leader

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in innovative medicine

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Earnings Preview: What to watch as Intel (INTC) prepares to report Q4 results

For Intel Corporation (NASDAQ: INTC), 2025 marked a recovery year, as the company made notable progress towards achieving its technological and operational milestones. After losing significant market share to rivals

January 13, 2026

Key takeaways from Delta Air Lines’ (DAL) Q4 2025 earnings report

Shares of Delta Air Lines (NYSE: DAL) were down over 2% on Tuesday after the company published its fourth quarter 2025 earnings report. While the top line surpassed estimates, the

January 13, 2026

Highlights of JPMorgan’s (JPM) Q4 2025 earnings report

Banking giant JPMorgan Chase & Co. (NYSE: JPM) on Tuesday announced financial results for the fourth quarter of fiscal 2025, reporting an increase in revenues. Reported net revenue increased 7%

January 13, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top